Post-mortem tissues from AD patients indeed display increased GFAP levels in temporal (Griffin et al., 1989, Simpson et al., 2010), occipital, parietal and frontal lobes (Kashon et al., 2004). Here, GFAP is linked to Alzheimer disease.